Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial

Nom du journal : Ann Oncol

Année : 2011

Volume : 22

Page de départ : 2201

Page de fin : 2207

Auteurs: Viale G, Regan MM, Dell'Orto P, Mastropasqua MG, Maiorano E, Rasmussen BB, MacGrogan G, Forbes JF, Paridaens RJ, Colleoni M, Lang I, Thürlimann B, Mouridsen H, Mauriac L, Gelber RD, Price KN, Goldhirsch A, Gusterson BA, Coates AS, for the BIG 1-98 Collaborative and International Breast Cancer Study Groups, Trocoli A,